Markets:

Overview

News

Currencies

International

Treasuries

Solventum Corporation Common Stock (NY:SOLV)

85.86 -0.28 (-0.33%)

Streaming Delayed Price Updated: 9:46 AM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 28, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Why Solventum (SOLV) Stock Is Down Today

February 28, 2025

Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed. On the other...

Via StockStory

Topics Initial Public Offering

Friday's session: top gainers and losers in the S&P500 index ↗

February 28, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

3M Stock: Buy, Sell, or Hold? ↗

February 04, 2025

Via The Motley Fool

5 Analysts Have This To Say About Solventum ↗

December 04, 2024

Via Benzinga

Critical Insights From Solventum Analyst Ratings: What You Need To Know ↗

November 11, 2024

Via Benzinga

Which S&P500 stocks are gapping on Friday? ↗

February 28, 2025

Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Friday's pre-market session: top gainers and losers in the S&P500 index ↗

February 28, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

Solventum: Q4 EPS Beats, Cash Flow Dips ↗

February 28, 2025

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures.

Via The Motley Fool

Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates

February 27, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per...

Via StockStory

Topics Artificial Intelligence Economy

Trian Comments on Solventum’s Sale of its Purification & Filtration Business

February 26, 2025

From Trian Fund Management, L.P.

Via GlobeNewswire

Decoding 4 Analyst Evaluations For Solventum ↗

September 26, 2024

Via Benzinga

Deep Dive Into Solventum Stock: Analyst Perspectives (5 Ratings) ↗

September 05, 2024

Via Benzinga

Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 26, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results tomorrow afternoon. Here’s what to look for.

Via StockStory

Solventum Shares Are Up Today: What's Going On? ↗

February 25, 2025

Solventum shares are trading higher Tuesday after the company announced it will sell its purification and filtration business to Thermo Fisher for $4.1 billion in cash.

Via Benzinga

Which S&P500 stocks are moving on Tuesday? ↗

February 25, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

Via Chartmill

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 25, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion ↗

February 25, 2025

Thermo Fisher will acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction portfolio with expected long-term growth.

Via Benzinga

3 Reasons to Sell SOLV and 1 Stock to Buy Instead

February 17, 2025

Solventum has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.9%. The stock now trades at $74.24, marking a 24.9% gain. This was partly due to its solid...

Via StockStory

Topics Stocks

Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

February 11, 2025

From Ampersand Biomedicines

Via GlobeNewswire

Where Will 3M Stock Be in 3 Years? ↗

January 13, 2025

This former Dividend King isn't out of the woods yet.

Via The Motley Fool

Trian Issues Open Letter to Solventum Shareholders

January 08, 2025

From Trian Fund Management, L.P.

Via GlobeNewswire

8 Health Care Stocks Whale Activity In Today's Session ↗

January 08, 2025

Via Benzinga

Honeywell Pops As It Mulls This Move Echoing GE Aerospace ↗

December 16, 2024

A standalone Honeywell aerospace business could be worth up to $120 billion.

Via Investor's Business Daily

Nelson Peltz's Trian Fund Management Reshaped Portfolio Ahead Of Presidential Election ↗

November 14, 2024

Trian Fund Management reshaped its portfolio in Q3. The moves come as Donald Trump's election victory is expected to bring significant economic policy shifts.

Via Benzinga

Topics Government

The Second-Best Dow Jones Stock Of 2024 Dives After Earnings Beat ↗

October 22, 2024

3M stock, Dow Jones Industrial Average component, flirted with a breakout on Tuesday morning after reporting better than expected earnings.

Via Investor's Business Daily

Topics Stocks

Solventum Stock Earns 81 RS Rating ↗

October 15, 2024

Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.

Via Investor's Business Daily

Don't Miss Out on These Top 3 Stocks for a September to Remember

September 03, 2024

September may have a reputation, but investors can find opportunities for growth and value by focusing on solid fundamentals and business models.

Via MarketBeat

Patchy But Still Bullish ↗

September 02, 2024

Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.

Via Talk Markets

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.